Prospective study on identification of effectiveness, safety and effect predictors of benralizumab for bronchial asthma

Trial Profile

Prospective study on identification of effectiveness, safety and effect predictors of benralizumab for bronchial asthma

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 19 Apr 2018

At a glance

  • Drugs Benralizumab (Primary)
  • Indications Asthma
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms J-BEST
  • Most Recent Events

    • 18 Apr 2018 Status changed from not yet recruiting to recruiting.
    • 03 Apr 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top